Published in Circulation on March 01, 1982
ADHD drugs and serious cardiovascular events in children and young adults. N Engl J Med (2011) 3.12
Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial. Br Heart J (1992) 2.99
Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation (2010) 2.94
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation (2009) 2.57
Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women. JAMA (2011) 2.34
Socioeconomic status and incidence of sudden cardiac arrest. CMAJ (2011) 2.31
Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation. J Am Coll Cardiol (2012) 2.18
Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol (2013) 2.16
A computer case definition for sudden cardiac death. Pharmacoepidemiol Drug Saf (2010) 1.97
Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women. Circulation (2009) 1.74
Epidemiology and genetics of sudden cardiac death. Circulation (2012) 1.65
Light-to-moderate alcohol consumption and risk of sudden cardiac death in women. Heart Rhythm (2010) 1.61
A common variant at 9p21 is associated with sudden and arrhythmic cardiac death. Circulation (2009) 1.59
Roadway proximity and risk of sudden cardiac death in women. Circulation (2014) 1.52
A common missense variant in the neuregulin 1 gene is associated with both schizophrenia and sudden cardiac death. Heart Rhythm (2013) 1.47
Structural neuroplasticity following T5 spinal cord transection: increased cardiac sympathetic innervation density and SPN arborization. Am J Physiol Regul Integr Comp Physiol (2010) 1.47
Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls. Circ Arrhythm Electrophysiol (2014) 1.44
Identification of a sudden cardiac death susceptibility locus at 2q24.2 through genome-wide association in European ancestry individuals. PLoS Genet (2011) 1.38
Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description. J Am Heart Assoc (2013) 1.30
The spectrum of epidemiology underlying sudden cardiac death. Circ Res (2015) 1.26
Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. J Interv Card Electrophysiol (2004) 1.26
Impact of age and sex on sudden cardiovascular death following myocardial infarction. Heart (2002) 1.24
Common variants in cardiac ion channel genes are associated with sudden cardiac death. Circ Arrhythm Electrophysiol (2010) 1.22
Rationale and design for the Defibrillators to Reduce Risk by Magnetic Resonance Imaging Evaluation (DETERMINE) trial. J Cardiovasc Electrophysiol (2009) 1.15
Sudden death in patients receiving drugs tending to prolong the QT interval. Br J Clin Pharmacol (2009) 1.08
Baroreflex sensitivity and cardiovascular mortality in patients with mild to moderate heart failure. Br Heart J (1995) 1.07
Plasma and dietary magnesium and risk of sudden cardiac death in women. Am J Clin Nutr (2010) 1.04
Repolarization abnormalities and afterdepolarizations in a canine model of sudden cardiac death. Am J Physiol Regul Integr Comp Physiol (2008) 1.02
Dietary fat quality and risk of sudden cardiac death in women. Am J Clin Nutr (2012) 1.02
Long-term impact of multivessel disease on cause-specific mortality after ST elevation myocardial infarction treated with reperfusion therapy. Heart (2006) 1.00
Clinical Course After Cardioverter-Defibrillator Implantation: Chagasic Versus Ischemic Patients. Arq Bras Cardiol (2016) 0.98
Predicting sudden death in patients with mild to moderate chronic heart failure. Heart (2004) 0.97
Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study. Heart (2004) 0.94
Relationship between left ventricular lead position using a simple radiographic classification scheme and long-term outcome with resynchronization therapy. J Interv Card Electrophysiol (2008) 0.90
A common variant in the β2-adrenergic receptor and risk of sudden cardiac death. Heart Rhythm (2011) 0.90
Mechanisms of sudden cardiac death. Indian Heart J (2014) 0.88
Out-of-hospital mortality among patients receiving methadone for noncancer pain. JAMA Intern Med (2015) 0.86
Intake of total trans, trans-18:1, and trans-18:2 fatty acids and risk of sudden cardiac death in women. Am Heart J (2009) 0.86
Propoxyphene and the risk of out-of-hospital death. Pharmacoepidemiol Drug Saf (2013) 0.85
Smoking, smoking cessation, and risk of sudden cardiac death in women. Circ Arrhythm Electrophysiol (2012) 0.84
Rationale and design of the Pan-African Sudden Cardiac Death survey: the Pan-African SCD study. Cardiovasc J Afr (2014) 0.83
Partial hindlimb occlusion reduced the susceptibility to sustained ventricular tachycardia in conscious rats. J Cardiovasc Pharmacol Ther (2009) 0.83
The prognosis of implantable defibrillator patients treated with cardiac resynchronization therapy: comorbidity burden as predictor of mortality. Europace (2010) 0.83
Epidemiology of sudden cardiac death in rural South India - insights from the andhra pradesh rural health initiative. Indian Pacing Electrophysiol J (2011) 0.83
Electrocardiographic predictors of sudden and non-sudden cardiac death in patients with ischemic cardiomyopathy. Heart Lung (2014) 0.82
Utility of electrophysiological studies to predict arrhythmic events. World J Cardiol (2015) 0.82
Association of apical rocking with long-term major adverse cardiac events in patients undergoing cardiac resynchronization therapy. Eur Heart J Cardiovasc Imaging (2015) 0.82
Reduction of inappropriate ICD therapies in patients with primary prevention of sudden cardiac death: DECREASE study. Clin Res Cardiol (2015) 0.81
Neurohormonal intervention to reduce sudden cardiac death in heart failure: what is the optimal pharmacologic strategy? Heart Fail Rev (2004) 0.81
Sudden cardiac death after myocardial infarction in type 2 diabetic patients with no residual myocardial ischemia. Diabetes Care (2012) 0.81
Cardiac Resynchronization Therapy in CKD Stage 4 Patients. Clin J Am Soc Nephrol (2015) 0.81
The genetics of sudden cardiac death. Annu Rev Genomics Hum Genet (2012) 0.81
Vitamin E supplementation and the risk of heart failure in women. Circ Heart Fail (2012) 0.81
Ventricular arrhythmias in congestive heart failure: clinical significance and management. Tex Heart Inst J (1999) 0.80
Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study. Am J Kidney Dis (2015) 0.79
The wearable cardioverter-defibrillator in a real-world clinical setting: experience in 102 consecutive patients. Clin Res Cardiol (2016) 0.79
Sudden Cardiac Death Among Hemodialysis Patients. Am J Kidney Dis (2017) 0.78
Cardiac spinal deafferentation reduces the susceptibility to sustained ventricular tachycardia in conscious rats. Am J Physiol Regul Integr Comp Physiol (2011) 0.78
Reperfusion-induced sustained ventricular tachycardia, leading to ventricular fibrillation, in chronically instrumented, intact, conscious mice. Physiol Rep (2014) 0.78
Validation of a computer case definition for sudden cardiac death in opioid users. BMC Res Notes (2012) 0.78
Risk stratification for arrhythmic death in an emergency department cohort: a new method of nonlinear PD2i analysis of the ECG. Ther Clin Risk Manag (2008) 0.78
Outcomes in heart failure patients referred for consideration of implantable cardioverter defibrillator for primary prophylaxis of sudden cardiac death: what are the risks of waiting? Can J Cardiol (2009) 0.77
Supraventricular tachyarrhythmia as a cause of sudden cardiac arrest. J Interv Card Electrophysiol (2006) 0.77
Designation and distribution of events in the Multicenter UnSustained Tachycardia Trial (MUSTT). Am J Cardiol (2007) 0.77
Long-term follow-up of patients with chronic chagas disease and implantable cardioverter-defibrillator. Pacing Clin Electrophysiol (2014) 0.77
ECG quantification of myocardial scar and risk stratification in MADIT-II. Ann Noninvasive Electrocardiol (2013) 0.76
Devices for the management of ventricular arrhythmias in cardiac failure. Heart Fail Rev (2002) 0.76
Comparison of linear-stochastic and nonlinear-deterministic algorithms in the analysis of 15-minute clinical ECGs to predict risk of arrhythmic death. Ther Clin Risk Manag (2009) 0.76
Long-term surgical results in sudden death syndrome associated with cardiac dysfunction after myocardial infarction. Ann Surg (1992) 0.75
Impact of denervated myocardium on improving risk stratification for sudden cardiac death. Trans Am Clin Climatol Assoc (2014) 0.75
Risk of arrhythmic death in ischemic heart disease: a prospective, controlled, observer-blind investigation over 10 years. Eur J Clin Invest (2017) 0.75
Effectiveness of structured, hospital-based, nurse-led atrial fibrillation clinics: a comparison between a real-world population and a clinical trial population. Open Heart (2016) 0.75
Use of azithromycin and risk of ventricular arrhythmia. CMAJ (2017) 0.75
Development and Validation of a Sudden Cardiac Death Prediction Model for the General Population. Circulation (2016) 0.75
Omega-3 polyunsaturated fatty acids and cardiac rhythm: an introduction. Front Physiol (2012) 0.75
Adiposity throughout adulthood and risk of sudden cardiac death in women. JACC Clin Electrophysiol (2015) 0.75
Sudden cardiac death risk prediction: comment on "Risk factor and prediction modeling for sudden cardiac death in women with coronary artery disease". Arch Intern Med (2011) 0.75
Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis. J Interv Card Electrophysiol (2008) 0.75
Adjudication of mortality events in a heart failure-arrhythmia trial by a multiparameter descriptive method: comparison with methods used in heart failure trials and methods used in arrhythmia trials. J Interv Card Electrophysiol (2008) 0.75
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer (1994) 5.63
Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52
Occupation, education, and coronary heart disease. Risk is influenced more by education and background than by occupational experiences, in the Bell System. Science (1968) 4.07
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res (2000) 3.83
Surgical management of renal tumors 4 cm. or less in a contemporary cohort. J Urol (2000) 3.26
Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg (1995) 3.24
The frequency of asymptomatic disturbances of cardiac rhythm and conduction in middle-aged men. Am J Cardiol (1969) 3.21
Distribution of brain metastases. Arch Neurol (1988) 3.11
Decreased growth of established human prostate LNCaP tumors in nude mice fed a low-fat diet. J Natl Cancer Inst (1995) 2.70
Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res (1994) 2.46
Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: is it accurate? J Urol (1996) 2.30
Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med (1993) 2.22
Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy. Neurology (1990) 2.13
The memorial symptom assessment scale short form (MSAS-SF). Cancer (2000) 1.94
The measurement of symptoms in children with cancer. J Pain Symptom Manage (2000) 1.85
Merkel cell carcinoma. Prognosis and management. Arch Surg (1991) 1.72
Adult brainstem gliomas. Neurology (1998) 1.61
Perforation of the gastrointestinal tract in patients receiving steroids for neurologic disease. Neurology (1988) 1.59
Steroid myopathy in cancer patients. Neurology (1997) 1.57
The importance of the quality of indoor air. Bull N Y Acad Med (1981) 1.55
Combined modality therapy for primary CNS lymphoma. J Clin Oncol (1992) 1.53
Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol (1998) 1.53
Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol (1995) 1.47
Neuropsychological characterization of the AIDS dementia complex: a preliminary report. AIDS (1988) 1.46
Association between initial diagnostic procedure and hysteroscopy and abnormal peritoneal washings in patients with endometrial carcinoma. Cancer (2000) 1.41
The role of postoperative radiotherapy after resection of single brain metastases. Neurosurgery (1989) 1.40
The importance of clinical staging of minor salivary gland carcinoma. Am J Surg (1991) 1.26
Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma. Am J Surg Pathol (1977) 1.25
Prognosis of node-positive colon cancer. Cancer (1991) 1.23
Quality of life of women with ovarian cancer. Gynecol Oncol (1995) 1.19
Prostaglandins in breast cancer: relationship to disease stage and hormone status. Br J Cancer (1983) 1.19
The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer (1992) 1.18
How accurate is fetal biometry in the assessment of fetal age? Am J Obstet Gynecol (1998) 1.18
The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function. Clin Pharmacol Ther (1992) 1.18
The non-Hodgkin's lymphomas. I. A retrospective clinical and pathologic analysis of 499 cases diagnosed between 1958 and 1969. Cancer (1983) 1.18
The single supratentorial lesion. An evaluation of preoperative diagnostic tests. J Neurosurg (1980) 1.16
Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood (2000) 1.10
Immunologic reactivity in patients with primary operable breast cancer. Cancer (1978) 1.10
Tape recordings of the ECG of active men. Limitations and advantages of the Holter-Avionics instruments. Circulation (1967) 1.10
II. An Examination of the Relation Between Symptoms, Disability, and Serious Illness, in Two Homogeneous Groups of Men and Women. Am J Public Health Nations Health (1960) 1.08
Fall in plasma content of free fatty acids associated with sight of food. N Engl J Med (1966) 1.07
The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology (1990) 1.05
Serologic detection of a y-linked gene in xx males and xx true hermaphrodites. N Engl J Med (1976) 1.04
Quality of life and survival: the role of multidimensional symptom assessment. Cancer (1998) 1.03
MRI demonstrates descending transtentorial herniation. Neurology (1988) 1.03
Risk factors associated with vasovagal reactions during colonoscopy. Gastrointest Endosc (1993) 1.02
Pathogenesis of an unexpected sudden death: role of early cycle ventricular premature contractions. Am J Cardiol (1977) 1.01
Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone. J Pediatr (1996) 1.00
Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg (1995) 1.00
A prospective randomized trial of single versus multiple drains in the axilla after lymphadenectomy. Surg Gynecol Obstet (1992) 1.00
Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect. Cancer (1992) 0.98
Nativity, complications, and pathology are determinants of surgical results for gastric cancer. Cancer (1994) 0.97
Gastrointestinal cancer studies in the human to nude mouse heterotransplant system. Gastroenterology (1977) 0.97
Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies. Neurology (1994) 0.95
Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria. Br J Haematol (2001) 0.95
Slow heart rates and increased risk of cardiac death in middle-aged men. Arch Intern Med (1972) 0.95
A long-term clinical follow-up of children with acute lymphoblastic leukemia treated with intensive chemotherapy regimens. Cancer (1980) 0.94
Lymphocyte transformation induced by autologous cells. XI. The effect of age on the autologous mixed lymphocyte reaction. Immunology (1981) 0.94
Favorable short-term and long-term outcome after elective radical rectal cancer resection in patients 75 years of age or older. Dis Colon Rectum (2000) 0.94
Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma. J Cancer Res Clin Oncol (1992) 0.93
Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients. Pain (1995) 0.92
Expression of transforming growth factor alpha in human gliomas. Oncogene (1990) 0.92
Influence of diet on vascular lesions in autoimmune-prone B/W mice. Proc Natl Acad Sci U S A (1983) 0.91
Limitations of family cancer history assessment at initial surgical consultation. Dis Colon Rectum (2001) 0.91
The risk factors for arrhythmic death in a sample of men followed for 20 years. Am J Epidemiol (1988) 0.90
Pap smears in women with endometrial carcinoma. Acta Cytol (2001) 0.89
The concept of "stress" in the biological and social sciences. Int J Psychiatry Med (1974) 0.89
The prognostic significance of ventricular premature contractions in healthy people and in people with coronary heart disease. Acta Cardiol (1974) 0.88
A dose-response study of dexamethasone in a model of spinal cord compression caused by epidural tumor. J Neurosurg (1989) 0.87
Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis. Am J Med (1988) 0.87
A prospective analysis of vascular access device-related infections in children. J Pediatr Surg (1992) 0.87
Pulmonary function in preterm infants following treatment with intravenous indomethacin. Am J Dis Child (1989) 0.86
Selective loss of KGDHC-enriched neurons in Alzheimer temporal cortex: does mitochondrial variation contribute to selective vulnerability? J Mol Neurosci (2001) 0.86
A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients. Brain Imaging Behav (2013) 0.84
High dose versus low dose dexamethasone in experimental epidural spinal cord compression. Neurosurgery (1988) 0.83
Effects of nutrition on disease and life span. I. Immune responses, cardiovascular pathology, and life span in MRL mice. Am J Pathol (1984) 0.83
Experimental meningeal carcinomatosis selectively depresses local cerebral glucose utilization in rat brain. Neurology (1989) 0.83
Combination chemotherapy of advanced chronic lymphocytic leukemia: the M-2 protocol (vincristine, BCNU, cyclophosphamide, melphalan, and prednisone). Blood (1982) 0.83
Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor. Neurology (1997) 0.82
Neuronal precursors of the adult rat subependymal zone persist into senescence, with no decline in spatial extent or response to BDNF. J Neurobiol (1997) 0.81
Carnitine, carnitine acetyltransferase, and glutathione in Alzheimer brain. Neurochem Res (1995) 0.81
Treatment of squamous cell carcinoma of the anal canal. Cancer (1991) 0.81
Single brain metastases: surgery plus radiation or radiation alone. Neurology (1986) 0.81
Treatment of advanced diffuse histiocytic lymphoma: an analysis of prognostic variables. Cancer (1982) 0.81
Relationship between cognitive status and behavioral symptoms in Alzheimer's disease and mixed dementia. J Am Geriatr Soc (1993) 0.81
Chronic morphine therapy for cancer pain: plasma and cerebrospinal fluid morphine and morphine-6-glucuronide concentrations. Neurology (1991) 0.80
The immediate antecedents of sudden death. Acta Med Scand Suppl (1981) 0.80
Reinfusion of mediastinal blood after heart surgery. J Thorac Cardiovasc Surg (2000) 0.80
Acute high-dose methotrexate neurotoxicity in the rat. Ann Neurol (1986) 0.79
Short-term risk factors for sudden death. Ann N Y Acad Sci (1982) 0.79
Prostaglandins in carcinomas of the head and neck. Cancer Lett (1984) 0.79
Multivariate analysis of T-cell functional defects and circulating serum factors in Hodgkin's disease. Cancer (1981) 0.79
Screening mammography: value in women 35-39 years old. AJR Am J Roentgenol (1993) 0.79
A model of radiation myelopathy in the rat. Pathology, regional capillary permeability changes and treatment with dexamethasone. Brain (1988) 0.78
Prostaglandins in cells of the lymphoid system in AKR leukemia. Cancer Res (1984) 0.78
Effects of xenon and krypton on regional cerebral blood flow in the rat. J Cereb Blood Flow Metab (1985) 0.77
Effects of nutrition of disease and life span. II. Vascular disease, serum cholesterol, serum thromboxane, and heart-produced prostacyclin in MRL mice. Am J Pathol (1984) 0.77
Factor analysis of the immunophenotypes of astrocytomas and malignant gliomas: correlations with tumor grade and patient survival. J Neurooncol (1990) 0.77
Surgical treatment of single brain metastasis. Evaluation of results by computerized tomography scanning. J Neurosurg (1980) 0.77